|Lu, Shan||University of Massachusetts Medical School||Worcester|
MD, PhD, MHA, is a physician scientist and a leader in novel vaccine research including vaccines against emerging infectious diseases. Currently he is Head of Laboratory of Nucleic Acid Vaccines and professor of Departments of Medicine, Biochemistry and Molecular Pharmacology at the University of Massachusetts Medical School (UMMS), Worcester, Massachusetts, USA. He is also UMMS' co-director of Center for AIDS Research (CFAR) and Associate Director of Medicine Residency Program. He holds adjunct faculty appointment at several Chinese academic institutions and is an Executive Board member of China AIDS Vaccine Initiative (CAVI). He is the current president of International Society for Vaccines (ISV) and served as the co-chair for the 2nd to 6th Vaccine and ISV Annual Global Congresses. Dr. Lu's research focuses on the induction of protective antibody responses by novel vaccination strategies with funding support from the US NIH and the Gates Foundation. His team conducted world's first DNA prime-protein boost HIV-1 vaccine clinical trial and elicited cross-reactive neutralizing antibody responses in humans - a major progress in AIDS vaccine development.